ReachMD
Be part of the knowledge.™Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
Episodes 16-30 of 62
Compassionate Communication: Keeping the Patient and Family Informed Throughout the Patient’s Journey Through the Four Stages With Rett Syndrome
MinuteCE®Compassionate Communication: Keeping the Patient and Family Informed Throughout the Patient’s Journey Through the Four Stages With Rett Syndrome
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Introductory Module
CME/CEUnderstanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Introductory Module
Expert Recommended Best Practices: Treatment Strategies for Parkinson's Disease Psychosis
MinuteCE®Expert Recommended Best Practices: Treatment Strategies for Parkinson's Disease Psychosis
Routine Screening for Psychotic Symptoms in Individuals with Parkinson’s Disease Psychosis Leads to Earlier Diagnosis
MinuteCE®Routine Screening for Psychotic Symptoms in Individuals with Parkinson’s Disease Psychosis Leads to Earlier Diagnosis
Psychotic Symptoms in Parkinson’s Disease Psychosis Disrupts Lives: Early Treatment Intervention Makes a Difference
MinuteCE®Psychotic Symptoms in Parkinson’s Disease Psychosis Disrupts Lives: Early Treatment Intervention Makes a Difference
Parkinson’s Disease Psychosis: A Case of Delusions, Diagnosis and Therapeutic Management
MinuteCE®Parkinson’s Disease Psychosis: A Case of Delusions, Diagnosis and Therapeutic Management
Case Study: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinson’s Disease Psychosis
MinuteCE®Case Study: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinson’s Disease Psychosis
Develop the Plan, Work the Plan: Integrating Ongoing Patient Assessments for Parkinson’s Disease Psychosis
MinuteCE®Develop the Plan, Work the Plan: Integrating Ongoing Patient Assessments for Parkinson’s Disease Psychosis
The Building Blocks: Early Recognition, Assessment, and Treatment Intervention for Parkinson’s Disease Psychosis
MinuteCE®The Building Blocks: Early Recognition, Assessment, and Treatment Intervention for Parkinson’s Disease Psychosis
The Future of Multiple Sclerosis Patient Care: Personalized Medicine Through Digital Health
Medical Industry FeatureThe Future of Multiple Sclerosis Patient Care: Personalized Medicine Through Digital Health
Advances in Temporal Lobe Epilepsy Research
NeuroFrontiersAdvances in Temporal Lobe Epilepsy Research
